NobleOak Life (NOL) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
12 Jun, 2026Executive summary
In-force premiums grew 22% year-over-year to AUD 387 million, exceeding guidance and industry growth rates, with new business up 18% to AUD 54.4 million.
Underlying NPAT increased 19% to AUD 15 million, driven by disciplined underwriting, expense management, and higher interest rates.
Market share in in-force premiums rose to 3.3%, with direct channel share at 8.7% and strategic partner channel at 2.7%.
Recognized as Australia's most awarded direct life insurer for the fifth consecutive year.
Achieved free cash flow generation for the first time, supporting future growth and potential dividends.
Financial highlights
In-force premium grew 22%, surpassing the 15%-20% guidance range, with new business up 18% to AUD 54.4 million.
Underlying earnings per share was AUD 0.1697 on a fully diluted basis; reported diluted EPS at AUD 0.1049.
Net insurance premium revenue rose 27% to AUD 98.6 million; investment return improved to 1.6% of insurance premium.
Lapse rate at 11.0%, about 4 percentage points below industry average; capital adequacy multiple at 193% with AUD 8.7 million surplus above target.
Direct channel underlying NPAT up 48% to AUD 5.9 million; strategic partner channel underlying NPAT up 6% to AUD 8.3 million; Genus segment NPAT at AUD 0.8 million.
Outlook and guidance
Expects to outperform the market in FY 2025 with above-market in-force premium growth and margin stability.
Plans to invest in omni-channel experience, marketing, technology, and digital transformation to drive growth and customer retention.
Free cash flow generation to support organic and potential inorganic growth, as well as possible future dividends.
Latest events from NobleOak Life
- 20% in-force premium growth and 22% higher underlying NPAT, with strong FY26 outlook.NOL
H2 202512 Jun 2026 - In-force premium up 19% and underlying NPAT up 11%, with strong growth outlook reaffirmed.NOL
H1 202612 Jun 2026 - 20% in-force premium growth and 11% NPAT increase, with strong capital and digital investment.NOL
H1 202512 Jun 2026 - Strong growth, digital transformation, and all resolutions passed with overwhelming support.NOL
AGM 20253 Feb 2026 - Strong growth, board renewal, and digital investment position for future success.NOL
AGM 202412 Jan 2026